Large-capitalization U.S. stocks have outperformed virtually all comers over the past 15 years. According to some of the world's largest investment banks, that is unlikely to change in 2025.

MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral ...